MWA
DGX icon

Medallion Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Medallion Wealth Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Hold
68
– – ﹤0.01% 683
2026
Q1 		$13.3K Sell
68
-50
-42% -$9.71K ﹤0.01% 725
2025
Q4 		$20.5K Hold
118
– – 0.01% 638
2025
Q3 		$22.5K Hold
118
– – 0.01% 611
2025
Q2 		$21.2K Hold
118
– – 0.01% 610
2025
Q1 		$20K Hold
118
– – 0.01% 572
2024
Q4 		$19K Buy
+118
New +$18.4K 0.01% 563

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Medallion Wealth Advisors's DGX Position: Q2 2026 in Review

Medallion Wealth Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 68 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #683.

Medallion Wealth Advisors first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $22.5K in Q3 2025. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Medallion Wealth Advisors held 68 shares of Quest Diagnostics worth $14.4K as of Q2 2026.
  • Medallion Wealth Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Medallion Wealth Advisors's portfolio in Q2 2026, its #683 holding.
  • Medallion Wealth Advisors first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • Medallion Wealth Advisors's Quest Diagnostics position peaked at $22.5K in Q3 2025.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.